iCAD Overview
- Year Founded
-
1984
- Status
-
Public
- Employees
-
69
- Stock Symbol
-
ICAD
- Investments
-
8
- Share Price
-
$1.64
- (As of Friday Closing)
iCAD General Information
Description
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
Contact Information
Website
www.icadmed.comCorporate Office
- 98 Spit Brook Road
- Suite 100
- Nashua, NH 03062
- United States
Corporate Office
- 98 Spit Brook Road
- Suite 100
- Nashua, NH 03062
- United States
iCAD Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.64 | $1.52 | $1.18 - $2.65 | $43.2M | 26.4M | 170K | -$0.11 |
iCAD Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 14,498 | 28,112 | 24,965 | 146,270 |
| Revenue | 18,796 | 17,318 | 19,802 | 33,638 |
| EBITDA | (4,852) | (7,294) | (9,716) | (10,561) |
| Net Income | (2,280) | (4,847) | (13,656) | (11,245) |
| Total Assets | 38,939 | 41,418 | 51,705 | 62,191 |
| Total Debt | 469 | 461 | 672 | 1,155 |
iCAD Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
iCAD Comparisons
Industry
Financing
Details
000000
000000
iCAD Competitors (29)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Varian Medical Systems | Corporate Backed or Acquired | Palo Alto, CA | 0000 | 000000&0 | ||
| Synaptive Medical | Venture Capital-Backed | Toronto, Canada | 000 | 00000 | 000000 - 000 | 00000 |
| Sun Nuclear | Formerly PE-Backed | Melbourne, FL | 000 | 000000000000 | ||
| Mevion Medical Systems | Private Equity-Backed | Littleton, MA | 000 | 00000 | 00 000000 | 00000 |
| ContextVision | Corporation | Stockholm, Sweden | 00 | 00000000 |
iCAD Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
iCAD Patents
iCAD Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2019384179-A1 | System and method for assessing breast cancer risk using imagery | Pending | 23-Nov-2018 | 0000000000 | |
| EP-3884458-A1 | System and method for assessing breast cancer risk using imagery | Pending | 23-Nov-2018 | 0000000000 | |
| US-20220398721-A1 | System and method for assessing breast cancer risk using imagery | Pending | 23-Nov-2018 | 000000000 | 0 |
| JP-2022507955-A | Systems and methods for assessing breast cancer risk using images | Pending | 23-Nov-2018 | 000000000 | 0 |
| US-20200167920-A1 | System and method for assessing breast cancer risk using imagery | Active | 23-Nov-2018 | G06T7/0012 |
iCAD Executive Team (17)
| Name | Title | Board Seat |
|---|---|---|
| Dana Brown | Chief Executive Officer & Chairman | |
| Eric Lonnqvist | Chief Financial Officer, Finance & Chief Accounting Officer, Accounting | |
| Jonathan Go | Chief Technology Officer, Technology | |
| Brian Testa | Chief People Officer |
iCAD Board Members (16)
| Name | Representing | Role | Since |
|---|---|---|---|
| 000000 0000000 | Self | Board Member | 000 0000 |
| 0000 00000 | iCAD | Chief Executive Officer & Chairman | 000 0000 |
| 000000 000000 | Self | Board Member | 000 0000 |
| 000000000 000000 0 | Self | Director and Senior Advisor for Affiliated Managers Group, Inc | 000 0000 |
| 000000 00000 00 | Self | Board Member | 000 0000 |
iCAD Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
iCAD Acquisitions (8)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| VuCOMP | 13-Jan-2016 | 0000000000 | 00000 | Monitoring Equipment | 0000000 0 |
| VuCOMP (Breast Density software) | 29-Apr-2015 | 0000000000 | 00.00 | Decision/Risk Analysis | 0000000 0 |
| DermEbx | 15-Jul-2014 | 0000000000 | 000 | Therapeutic Devices | 0000000 0 |
| Radion | 15-Jul-2014 | 0000000000 | 00.00 | Other Healthcare Technology Systems | 0000000 0 |
| Xoft | 30-Dec-2010 | Merger/Acquisition | 000.00 | Other Devices and Supplies | 0000000 0 |
iCAD Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Qualia Computing | Hospitals/Inpatient Services | Beavercreek, OH | 0000 |
iCAD ESG
Risk Overview
Risk Rating
Updated April, 01, 2022
25.25 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.00
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,638
Rank
Percentile
Healthcare
Industry
00 of 636
Rank
Percentile
Health Care IT Services
Subindustry
00 of 32
Rank
Percentile
iCAD Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Xoft | 30-Dec-2010 | 000000000000 | 000.00 | Completed |
|
iCAD FAQs
-
When was iCAD founded?
iCAD was founded in 1984.
-
Who is the CEO of iCAD?
Dana Brown is the CEO of iCAD.
-
Where is iCAD headquartered?
iCAD is headquartered in Nashua, NH.
-
What is the size of iCAD?
iCAD has 69 total employees.
-
What industry is iCAD in?
iCAD’s primary industry is Diagnostic Equipment.
-
Is iCAD a private or public company?
iCAD is a Public company.
-
What is iCAD’s stock symbol?
The ticker symbol for iCAD is ICAD.
-
What is the current stock price of iCAD?
As of 13-Sep-2024 the stock price of iCAD is $1.64.
-
What is the current market cap of iCAD?
The current market capitalization of iCAD is $43.2M.
-
What is iCAD’s current revenue?
The trailing twelve month revenue for iCAD is $18.8M.
-
Who are iCAD’s competitors?
Varian Medical Systems, Synaptive Medical, Sun Nuclear, Mevion Medical Systems, and ContextVision are some of the 29 competitors of iCAD.
-
What is iCAD’s annual earnings per share (EPS)?
iCAD’s EPS for 12 months was -$0.11.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
